DAVITA INC. Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price
DAVITA INC. (DVA) had Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price of $119.18 per share as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 · last filed 2026-02-11
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $119.18.
- 2024-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $108.02.
- 2023-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $67.40.
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $66.00.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2025-12-31 | $119.18 10-K · filed 2026-02-11 |
| 2024-12-31 | $108.02 10-K · filed 2025-02-13 |
| 2023-12-31 | $67.40 10-K · filed 2024-02-14 |
| 2022-12-31 | $66.00 10-K · filed 2023-02-22 |
| 2021-12-31 | $64.66 10-K · filed 2022-02-11 |
| 2020-12-31 | $63.64 10-K · filed 2021-02-12 |
| 2019-12-31 | $64.10 10-K · filed 2020-02-21 |
| 2018-12-31 | $69.90 10-K · filed 2019-02-22 |
| 2017-12-31 | $67.92 10-K · filed 2018-02-23 |
| 2016-12-31 | $64.90 10-K · filed 2017-02-24 |
| 2015-12-31 | $59.05 10-K · filed 2016-02-26 |
| 2014-12-31 | $53.21 10-K · filed 2015-02-26 |
| 2013-12-31 | $45.44 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |